Emergent's 2023 Milestones Bolster America's Preparedness for Public Health Challenges, Securing Financial Resilience, Declares CEO Haywood Miller

Reports Q2 2023 total revenues of $338M, above the prior guidance range, net loss of $261M and adjusted EBITDA of $56M Updates FY 2023 guidance and prov...

August 09, 2023 | Wednesday | Company results
WuXi Vaccines' First Drug Substance Facility in China Now GMP-Ready

The GMP release of its first DS facility in China enhances WuXi Vaccines' capability in providing global partners with comprehensive end-to-end solutions, ...

July 28, 2023 | Friday | News
Samsung Biologics Reports Second Quarter 2023 Financial Results

  Recorded Q2’23 consolidated revenue of KRW 866.2 billion Recorded Q2’23 consolidated operating profit of KRW 253.4 billion&nbs...

July 27, 2023 | Thursday | News
Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility

“Samsung Biologics is fully committed to engaging in sustainable business practices for the positive impact it has on our clients, society, and the w...

July 18, 2023 | Tuesday | News
Syngene to acquire multi-modal facility from Stelis Biopharma Ltd

Syngene (or the “Company”) today announced the acquisition of Unit 3 biologics manufacturing facility in Bangalore, India, from Stelis Biopharm...

July 05, 2023 | Wednesday | News
Paras Biopharma Enhances Protein Expression in Microbial Systems for Cost-effective Biologics Production

The company is pleased to disclose its advancement of up to 12 g or more / L expression of recombinant protein - fully folded / biologically active in ferm...

July 04, 2023 | Tuesday | News
WuXi Biologics Announced Global Strategic Partnership with Pharmadule Morimatsu at its Singapore CRDMO Center Project

Under the partnership, Pharmadule Morimatsu will provide modular facilities for the WuXi Biologics Singapore CRDMO Center project.   This strategic ...

June 29, 2023 | Thursday | News
Enveric Biosciences Advances EB-373 with Phase 1 Formulation and Manufacturing Initiation.

Enveric to expand existing manufacturing agreement with CDMO partner for enhanced supply of non-GMP and GMP EB-373 drug substance Enveric Biosciences (NAS...

June 27, 2023 | Tuesday | News
South Korean SK pharmteco doubles viral vector production capacity in Europe

Yposkesi, SK pharmteco's clinical and commercial viral vector manufacturing subsidiary for Cell and Gene Therapy (C>), completes i...

June 23, 2023 | Friday | News
Dyadic Partners with Bangladesh's State-Owned Pharma for Biopharmaceutical Research and Manufacturing

“We are pleased to announce this strategic partnership with the government of Bangladesh, which demonstrates the company’s continued ability to...

June 22, 2023 | Thursday | News
Catalent Appoints Matti Masanovich Senior Vice President & Chief Financial Officer

Prior to joining Catalent, Mr. Masanovich served as Executive Vice President & Chief Financial Officer of Tenneco Automotive until it was acquired by A...

June 21, 2023 | Wednesday | News
Vetter Continues to Lead the Industry in Sustainability Initiatives

Report now includes Scope 3 emissions Employee-driven social responsibility takes precedence as driving force for sustainability activities Goal to red...

June 15, 2023 | Thursday | News
Samsung Biologics and Pfizer announce strategic collaboration for long-term manufacturing of biosimilars portfolio

Under the terms of the new agreement, Samsung Biologics will provide Pfizer with additional capacity for large-scale manufacturing for a multi-product bios...

June 12, 2023 | Monday | News
Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration

Charles River Laboratories International, Inc. (NYSE: CRL) and the INADcure Foundation, a nonprofit organization whose mission is to support the developmen...

June 09, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close